INS and type 1 diabetes mellitus: These changes initially raised concerns about new-onset or coexisting type 1 diabetes mellitus; however, the reversibility of anti-glutamate decarboxylase antibody positivity and the eventual restoration of insulin secretion argued against a new or evolving form of autoimmune diabetes.